⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 20, 2024Open Access

Table S6 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial

Channing J. Paller Marianna Zahurak Adel Mandl Nicole A. Metri Aliya Lalji Elisabeth I. Heath William K. Kelly Christopher Hoimes Pedro C. Barata Jason Taksey Dominique A. Garrison Kartick Patra Ginger L. Milne Nicole M. Anders Julie M. Nauroth Jennifer N. Durham Catherine H. Marshall Mark C. Markowski Mario A. Eisenberger Emmanuel S. Antonarakis Michael A. Carducci Samuel R. Denmeade Mark Levine

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Table S6 shows AEs with Attribution Possible, Probable or Definite to Docetaxel listed by types and grades

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Paller et al. (2024) studied this question.

synapsesocial.com/papers/68e5bb1eb6db643587552dd8 https://doi.org/10.1158/2767-9764.26788837

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Table S6 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial2024
2Table S6 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial2024
3Table S6 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial2024
4Table S5 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial2024
5Table S5 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial2024
6Table S5 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial2024
7Table S5 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial2024
8Table S7 from High-Dose Intravenous Vitamin C Combined with Docetaxel in Men with Metastatic Castration-Resistant Prostate Cancer: A Randomized Placebo-Controlled Phase II Trial2024